Adiponectin Signaling Pathways in Liver Diseases
AbstractIn the liver, adiponectin regulates both glucose and lipid metabolism and exerts an insulin-sensitizing effect. The binding of adiponectin with its specific receptors induces the activation of a proper signaling cascade that becomes altered in liver pathologies. This review describes the different signaling pathways in healthy and diseased hepatocytes, also highlighting the beneficial role of adiponectin in autophagy activation and hepatic regeneration. View Full-Text
Share & Cite This Article
Gamberi, T.; Magherini, F.; Modesti, A.; Fiaschi, T. Adiponectin Signaling Pathways in Liver Diseases. Biomedicines 2018, 6, 52.
Gamberi T, Magherini F, Modesti A, Fiaschi T. Adiponectin Signaling Pathways in Liver Diseases. Biomedicines. 2018; 6(2):52.Chicago/Turabian Style
Gamberi, Tania; Magherini, Francesca; Modesti, Alessandra; Fiaschi, Tania. 2018. "Adiponectin Signaling Pathways in Liver Diseases." Biomedicines 6, no. 2: 52.
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.